Supply Chain

Deal expected to help expand its API production services

If given green light by European Commission, vaccine dose will be less than that of adolescents

Leslie Lotano-Saba, VP of Pharmacy Solutions at AArete, sizes up the problem and discusses the main factors driving these shortfalls, along with the class of medicines hardest hit.

GTS improvements include additional data integrity protection, greater Level 1 and 2 equipment compatibility

A chat with Cardinal Health’s Joel Wayment, who dives into what can be done to help ensure that patients receive their necessary medications, no matter the conditions

The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Advance purchase agreement is for up to 200 million doses of Nuvaxovid

Discussions will revolve around fortifying the pharma supply chain

Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector

Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden

Agreement provides pharma firms with an RWD and commercialization solution

The solution is a combination of cold chain logistics, serialization compliance and distribution

Today’s ideal pharma third-party logistics (3PL) provider brings the right mix of physical assets, internal expertise, data analytics and strategic partnerships to function as a seamless extension of a manufacturer’s internal operations—no matter what disruptions arise

The growing complexity and demand in distribution amid the pandemic present unique technology opportunities for third-party logistics providers

A conversation with Michael Abrams, co-founder and managing partner, Numerof & Associates

As more of these novel—and costly—cell therapies gain approval, revamped strategies around scaling, coordination and workflow are critical to their launch

Examining the divestment risks, as more large companies look to spin off consumer health and other business units to focus on branded pharmaceuticals

Can technology really build trust in pharmaceutical supply chains?

Quris’s system can help predict clinical safety, AI firm notes

Magellan Rx Management and Zipline have collaborated on a pilot project to deliver prescription medications directly to patients’ homes via autonomous aircraft. Magellan Rx CEO Mostafa Kamal discusses how this innovative delivery method aims to reduce barriers to care.

Collaboration, the companies note, is expected to further engage patients

Action offers the fulfillment of a critical part of the Drug Supply Chain Security Act (DSCSA)

A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report

USP study reveals urgency to make changes, with additional concerns coming to light amid times of crisis

Logistics provider’s investment will develop distribution area by an additional 27%

Acquisition expands Medable’s global engineering talent and gives company a third location in Europe

CDMO will use its BFS knowledge to support production out of its Kaysersberg, France plant

Following a November FDA public meeting, HDA reiterates the objections it had to guidance FDA issued in mid-2021 under the Drug Supply Chain Security Act (DSCSA)